FromAstraZeneca ([email protected])
Subject (141)Novel computational pathology-based TROP2 biomarker for Dato-DXd was predictive of clinical outcomes in patients with NSCLC in TROPION-Lung01
Preheader (150)Novel computational pathology-based TROP2 biomarker for datopotamab deruxtecan was predictive of clinical outcomes in patients with non-small cell lun
Arial
Text Analysis
Body Words492
Subject Words18
Body Emojis2
Subject Emojis
Media Analysis
Text Links16
Image Links8
Total Links24
Images14
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px1640 px
X-Spam Score-0.2
Preheader OptimizedNo
Timing
Day of WeekFriday
TimeEvening
